Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

New mutations in hair keratin genes cause the rare hair disorder monilethrix.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Clofazimine effectively treated ashy dermatosis in a patient.

Methotrexate treatment often causes hair loss.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

Axitinib treatment turned a man's grey hair back to black.

Many patients on methotrexate experience significant side effects but still continue the medication.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

A 308 nm excimer laser successfully treated a boy with a rare skin condition after about a year of weekly sessions.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

MEX3A is crucial for maintaining intestinal stem cells in mice.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Both treatments for localized alopecia areata are equally effective.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

New mutations in KRT83 and KRT86 are linked to the hair disorder monilethrix.

Prenatal diagnosis of trichothiodystrophy is possible in the second trimester using fetal eyebrow biopsy, with sulfur content analysis being more reliable.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Uterine transplants for transgender women are feasible but need more research.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.